Form 8-K - Current report:
SEC Accession No. 0001193125-22-289964
Filing Date
2022-11-21
Accepted
2022-11-21 16:31:36
Documents
14
Period of Report
2022-11-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d423922d8k.htm   iXBRL 8-K 25234
2 EX-99.1 d423922dex991.htm EX-99.1 77856
6 GRAPHIC g423922g04p51.jpg GRAPHIC 14705
  Complete submission text file 0001193125-22-289964.txt   250179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bioc-20221121.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20221121_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20221121_pre.xml EX-101.PRE 10813
8 EXTRACTED XBRL INSTANCE DOCUMENT d423922d8k_htm.xml XML 3266
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 221406183
SIC: 8071 Services-Medical Laboratories